Clinical Trial Update: Utility Study in Diffuse Large B-Cell Lymphoma (DLBCL)

View source ↗

Summary

The trial update notes completion of a utility study in Diffuse Large B-Cell Lymphoma sponsored by Hoffmann-La Roche.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Diffuse Large B-Cell Lymphoma | Status: COMPLETED